Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Casey

Showing results (401-410 of 429) with videos related to

Pageof 43
Sort By:
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity - IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024Kevin C Ma, Diya Surie, Adam S Lauring, et al.
MMWR. Morbidity and Mortality Weekly Report|February 29, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024Jennifer DeCuir, Amanda B Payne, Wesley H Self, et al.
MMWR. Morbidity and Mortality Weekly Report|September 23, 2021
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021Wesley H Self, Mark W Tenforde, Jillian P Rhoads, et al.
The Lancet. Respiratory Medicine|June 22, 2023
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trialSamuel M Brown, Christina E Barkauskas, Birgit Grund, et al.
JAMA|November 9, 2020
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical TrialWesley H Self, Matthew W Semler, Lindsay M Leither, et al.
Nature|June 11, 2004
A precision measurement of the mass of the top quarkV M Abazov, B Abbott, A Abdesselam, et al.
Physical Review Letters|September 16, 2000
Measurement of the W-->taunu production cross section in pp collisions at square root s=1.8 TeVB Abbott, M Abolins, V Abramov, et al.
Physical Review Letters|September 16, 2000
Probing Balitsky-Fadin-Kuraev-Lipatov dynamics in the dijet cross section at large rapidity intervals in pp collisions at sqrt[s]=1800 and 630 GeVB Abbott, M Abolins, V Abramov, et al.
Physical Review Letters|July 13, 2004
Search for narrow tt resonances in pp collisions at square root of (s)=1.8 TeVV M Abazov, B Abbott, A Abdesselam, et al.
Physical Review Letters|December 18, 2002
Search for the production of single sleptons through R-parity violation in pp; collisions at square root (s) =1.8 TeVV M Abazov, B Abbott, A Abdesselam, et al.
Pageof 43

Showing results (401-410 of 429) with videos related to

Sort By:
Pageof 43
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity - IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024Kevin C Ma, Diya Surie, Adam S Lauring, et al.
MMWR. Morbidity and Mortality Weekly Report|February 29, 2024
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024Jennifer DeCuir, Amanda B Payne, Wesley H Self, et al.
MMWR. Morbidity and Mortality Weekly Report|September 23, 2021
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021Wesley H Self, Mark W Tenforde, Jillian P Rhoads, et al.
The Lancet. Respiratory Medicine|June 22, 2023
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trialSamuel M Brown, Christina E Barkauskas, Birgit Grund, et al.
JAMA|November 9, 2020
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical TrialWesley H Self, Matthew W Semler, Lindsay M Leither, et al.
Nature|June 11, 2004
A precision measurement of the mass of the top quarkV M Abazov, B Abbott, A Abdesselam, et al.
Physical Review Letters|September 16, 2000
Measurement of the W-->taunu production cross section in pp collisions at square root s=1.8 TeVB Abbott, M Abolins, V Abramov, et al.
Physical Review Letters|September 16, 2000
Probing Balitsky-Fadin-Kuraev-Lipatov dynamics in the dijet cross section at large rapidity intervals in pp collisions at sqrt[s]=1800 and 630 GeVB Abbott, M Abolins, V Abramov, et al.
Physical Review Letters|July 13, 2004
Search for narrow tt resonances in pp collisions at square root of (s)=1.8 TeVV M Abazov, B Abbott, A Abdesselam, et al.
Physical Review Letters|December 18, 2002
Search for the production of single sleptons through R-parity violation in pp; collisions at square root (s) =1.8 TeVV M Abazov, B Abbott, A Abdesselam, et al.
Pageof 43